Panelists Joseph Alvarnas, MD; Elizabeth Carpenter; and John Fox, MD, describe the drug approval process, biosimilars, and drug costs, particularly how changes within the FDA approval process affect drug prices and how the FDA’s role helps bring drugs to the market faster.
The FDA has already approved 4 biosimilars in the United States, but there remains a lot of uncertainty surrounding some of the legislation and regulation.
Specialty pharmacy pipelines, healthy behaviors, and regulation took the stage at the Academy of Managed Care Pharmacy (AMCP)’s 2016 Nexus conference, which was held October 3-6 in National Harbor, Maryland.


COPD Compendium
Diabetes Compendium
GI Compendium
Lipids Compendium
MACRA Compendium
Oncology Compendium
Rare Disease Compendium
Reimbursement Compendium
Know Your News
HF Compendium